Unusal signs and symptoms associated with oral contraceptive medication
Koide, S.S.; Lyle, K.C.
Journal of Reproductive Medicine 15(6): 214-224
1975
ISSN/ISBN: 0024-7758 PMID: 1104827 Document Number: 87955
A review of medical history concerning case history reports of adverse clinical manifestations of hormonal contraceptives is presented. The unusual complicatons described are: gingivitis, dilation of the ureters, masculinization of the female fetus, candidiasis, ischemic colitis, megaloblastic anemia, chorea, alopecia, chloasma pigmentation, prophyria, photosensitivity, herpes gestationis, lupus, erythematous syndrone, erythema modosum and corneal irritation. The pathophysiology of the lesion and its relation to hormone action are presented.
Document emailed within 1 workday
Related Documents
Morotti, M.; Remorgida, V.; Venturini, P.L.; Ferrero, S. 2014: Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura European Journal of Obstetrics Gynecology and Reproductive Biology 179: 63-68Mateos Lindemann, M.L.; Morales, J.G.; Fernández-Barredo, S.; Domínguez, M.R.íg.; García de la Hoz, F.; Halfon, P.; Pérez Gracia, M.T. 2010: Fulminant hepatitis e in a woman taking oral contraceptive medication American Journal of Tropical Medicine and Hygiene 82(1): 12-15
Andersch, B. 1982: The effect of various oral contraceptive combinations on premenstrual symptoms International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 20(6): 463-469
Taneepanichskul, S.; Jaisamrarn, U.; Phupong, V. 2007: Effect of a new oral contraceptive with drospirenone on vital signs, complete blood count, glucose, electrolytes, renal, and liver function Journal of the Medical Association of Thailand 90(3): 426-431
Oh, S.H.; Kwon, J.Y.; Lee, J.H.; Han, E.C.; Bang, D. 2009: Behcet's disease: remission of patient symptoms after oral contraceptive therapy Clinical and Experimental Dermatology 34(5): E88-E90
Graham, C.A.; Sherwin, B.B. 1992: A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive Journal of Psychosomatic Research 36(3): 257-266
Graham, C.A.; Sherwin, B.B. 1993: The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms Psychoneuroendocrinology 18(4): 273-281
Nilsson, A.; Jacobson, L.; Ingemanson, C. 1968: Side-Effects of An Oral Contraceptive with Particular Attention to Mental Symptoms and Sexual Adaptation: Acta Psychiatrica Scandinavica 43(S 203): 259-260
Fortin, J.N.; Wittkower, E.D.; Paiement, J.; Tetreault, L. 1972: Psychosomatic medicine. Side effects of oral contraceptive medication: a psychosomatic problem Canadian Psychiatric Association Journal 17(1): 3-10
Bird, J.L.; Oinonen, K.A. 2011: Elevated eating disorder symptoms in women with a history of oral contraceptive side effects Archives of Women's Mental Health 14(4): 345-353
Sixel-Dietrich, F.; Doss, M. 1985: Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication Archives of Dermatological Research 278(1): 13-16
Sulak, P.J.; Kuehl, T.J.; Ortiz, M.; Shull, B.L. 2002: Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms American Journal of Obstetrics and Gynecology 186(6): 1142-1149
Hadji, P.; Biskup, J.; Boekhoff, J.; Ziller, M.; Bonn, M.; Rovati, L. 2012: Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg Contraception 86(4): 359-365
Nyberg, S. 2013: Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol Contraception 87(6): 773-781
Hall, K.Stidham.; White, K.O'Connell.; Rickert, V.I.; Reame, N.K.; Westhoff, C.L. 2013: An exploratory analysis of associations between eating disordered symptoms, perceived weight changes, and oral contraceptive discontinuation among young minority women Journal of adolescent health: official publication of the Society for Adolescent Medicine 52(1): 58-63
Hall, K.S.; White, K.O.'C.; Rickert, V.I.; Reame, N.; Westhoff, C. 2012: Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women Contraception 86(5): 518-525
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347
Rushton, L.; Jones, D.R. 1992: Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use British Journal of Obstetrics and Gynaecology 99(3): 239-246
Kaul, L.; Ahluwalia, B. 1978: Interrelation of caffeine and oral contraceptive steroid metabolism in hypertensive oral contraceptive users in humans Journal of Steroid Biochemistry 9(9): 862-863
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469